1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Non-Alcoholic Steatohepatitis Market – By Product

1.3.2        North America Non-Alcoholic Steatohepatitis Market – By Application

1.3.3        North America Non-Alcoholic Steatohepatitis Market – By Sales Channel

1.3.4        North America Non-Alcoholic Steatohepatitis Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Non-Alcoholic Steatohepatitis Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America PEST Analysis

4.3         Experts Opinion

5.           North America Non-alcoholic steatohepatitis (NASH) Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of NASH

5.1.2        Increasing Initiatives for the Awareness of NASH

5.2         Market Restraints

5.2.1        Lack of Established Guidelines in the Diagnosis and Management of NASH

5.2.2        Withdrawal of Drugs from Seeking Marketing Authorization for NASH

5.3         Market Opportunities

5.3.1        Growing Opportunities in Developing Nations

5.3.2        High Competition among Market Players to Manufacture the First Marketed NASH Drug Creates Global Sales Opportunity

5.4         Future Trends

5.4.1        Growing Clinical Trials Involving Combination Studies of Drugs

5.5         Impact Analysis

6.           Non-alcoholic steatohepatitis (NASH) Market– North America Analysis

6.1         North America Non-Alcoholic Steatohepatitis Market Revenue Forecast and Analysis

7.           North America Non-alcoholic steatohepatitis (NASH) Market Revenue and Forecasts To 2028– by Product

7.1         Overview

7.2         Product Market Revenue and Forecast Analysis (US$ Mn)

7.3         Vitamin E and Pioglitazone

7.3.1        Overview

7.3.2        Vitamin E and Pioglitazone Revenue and Forecast to 2028 (US$ Mn)

7.4         Ocaliva

7.4.1        Overview

7.4.2        Ocaliva Revenue and Forecast to 2028 (US$ Mn)

7.5         Elafibranor

7.5.1        Overview

7.5.2        Elafibranor Revenue and Forecast to 2028 (US$ Mn)

7.6         Selonsertib & Cenicriviroc

7.6.1        Overview

7.6.2        Selonsertib Revenue and Forecast to 2028 (US$ Mn)

7.7         Others

7.7.1        Overview

7.7.2        Others Revenue and Forecast to 2028 (US$ Mn)

8.           North America Non-Alcoholic Steatohepatitis (NASH) Market Analysis and Forecast to 2028 – by Application

8.1         Overview

8.2         Application Market Revenue and Forecast Analysis (US$ Mn)

8.3         Treatment

8.3.1        Overview

8.3.2        Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Diagnosis

8.4.1        Overview

8.4.2        Diagnosis Market Revenue and Forecast to 2028 (US$ Mn)

9.           North America Non-Alcoholic Steatohepatitis (NASH) Market Analysis and Forecast to 2028 – by Sales Channel

9.1         Overview

9.2         Sales Channel Market Revenue and Forecast Analysis (US$ Mn)

9.3         Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

9.5         Online Provider

9.5.1        Overview

9.5.2        Online Provider Market Revenue and Forecast to 2028 (US$ Mn)

10.        North America Non-alcoholic steatohepatitis (NASH) Market Revenue and Forecasts to 2028 – Country Analysis

10.1      North America: Non-Alcoholic Steatohepatitis Market

10.1.1     Overview

10.1.3     North America: Non-Alcoholic Steatohepatitis Market, by Country, 2021 & 2028 (%)

10.1.3.1       US: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3.1.1       US: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3.1.2       US: Non-Alcoholic Steatohepatitis Market, by Product, 2019–2028 (US$ Million)

10.1.3.1.3       US: Non-Alcoholic Steatohepatitis Market, by Application, 2019–2028 (US$ Million)

10.1.3.1.4       US: Non-Alcoholic Steatohepatitis Market, by Sales Channel, 2019–2028 (US$ Million)

10.1.3.2       Canada: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3.2.1       Canada: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3.2.2       Canada: Non-Alcoholic Steatohepatitis Market, by Product, 2019–2028 (US$ Million)

10.1.3.2.3       Canada: Non-Alcoholic Steatohepatitis Market, by Application, 2019–2028 (US$ Million)

10.1.3.2.4       Canada: Non-Alcoholic Steatohepatitis Market, by Sales Channel, 2019–2028 (US$ Million)

10.1.3.3       Mexico: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3.3.1       Mexico: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3.3.2       Mexico: Non-Alcoholic Steatohepatitis Market, by Product, 2019–2028 (US$ Million)

10.1.3.3.3       Mexico: Non-Alcoholic Steatohepatitis Market, by Application, 2019–2028 (US$ Million)

10.1.3.3.4       Mexico: Non-Alcoholic Steatohepatitis Market, by Sales Channel, 2019–2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Cadila Pharmaceuticals Ltd.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Intercept Pharmaceuticals, Inc

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Novartis AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Galmed Pharmaceuticals.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      GENFIT.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Prometheus Laboratories

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Siemens Healthineers AG

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Laboratory Corporation of America Holdings

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             US Non-Alcoholic Steatohepatitis Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Non-Alcoholic Steatohepatitis Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Non-Alcoholic Steatohepatitis Market, by Sales Channel – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Canada: Non-Alcoholic Steatohepatitis Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Canada Non-Alcoholic Steatohepatitis Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada Non-Alcoholic Steatohepatitis Market, by Sales Channel – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Mexico: Non-Alcoholic Steatohepatitis Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Mexico Non-Alcoholic Steatohepatitis Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico Non-Alcoholic Steatohepatitis Market, by Sales Channel – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Organic Developments Done By Companies

Table 11.          Inorganic Developments Done By Companies

Table 12.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Non-Alcoholic Steatohepatitis Market Segmentation

Figure 2.           North America Non-Alcoholic Steatohepatitis Market, By Country

Figure 3.           North America Non-Alcoholic Steatohepatitis Market Overview

Figure 4.           North America Non-Alcoholic Steatohepatitis Market, By Application

Figure 5.           North America Non-Alcoholic Steatohepatitis Market, By Country

Figure 6.           North America: PEST Analysis

Figure 7.           North America Experts Opinion

Figure 8.           North America Non-Alcoholic Steatohepatitis (NASH) Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Non-Alcoholic Steatohepatitis Market– Revenue Forecast and Analysis

Figure 10.        North America Product Market Analysis and Forecast 2021 and 2028 (%)

Figure 11.        North America Vitamin E and Pioglitazone Revenue and Forecast to 2028 (US$ Mn)

Figure 12.        North America Ocaliva Revenue and Forecast to 2028 (US$ Mn)

Figure 13.        North America Elafibranor Revenue and Forecast to 2028 (US$ Mn)

Figure 14.        North America Selonsertib Revenue and Forecast to 2028 (US$ Mn)

Figure 15.        North America Others Revenue and Forecast to 2028 (US$ Mn)

Figure 16.        North America Application Market Analysis and Forecast 2021 and 2028 (%)

Figure 17.        North America Treatment Market Revenue and Forecast to 2028 (US$ Mn)

Figure 18.        North America Diagnosis Market Revenue and Forecast to 2028 (US$ Mn)

Figure 19.        North America Sales Channel Market Analysis and Forecast 2021 and 2028 (%)

Figure 20.        North America Hospital Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

Figure 21.        North America Retail Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

Figure 22.        North America Online Provider Market Revenue and Forecast to 2028 (US$ Mn)

Figure 23.        North America: Non-Alcoholic Steatohepatitis Market, by Key Country – Revenue (2021) (US$ Million)

Figure 24.        North America: Non-Alcoholic Steatohepatitis Market, by Country, 2021 & 2028 (%)

Figure 25.        US: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Canada: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Mexico: Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (US$ Million)